Heritable genome editing to prevent severe disease is a duty, not a transgression.
“Ethics council recommends conditional approval of germline editing” — Nature, 2026-09-12
Obligations to a future person who does not yet exist, against the impossibility of their consent and the slide from therapy to preference.
- If consent is impossible either way, on what basis is inaction the safer default?
- Where exactly does prevention end and preference begin, and who is entitled to draw that line?